Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rank in Stocks #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Share Price
$2.03
Market Cap
$121.44M
Change (1 day)
-0.93%
Change (1 year)
-1.97%
Country
FR
Trade Crossject Société Anonyme (ALCJ)

Category

EPS for Crossject Société Anonyme (ALCJ)
EPS as of December 2025 TTM: $-0.25
According to Crossject Société Anonyme latest financial reports and stock price the company's current EPS (TTM) is $-0.25. At the end of 2023 the company had a EPS of $-0.25 a decrease compared to its 2022 EPS that were of $-0.33.
EPS history for Crossject Société Anonyme from 2010 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.25 -15.03%
2024 $-0.29 14.59%
2023 $-0.25 -23.52%
2022 $-0.33 -30.38%
2021 $-0.48 -4.35%
2020 $-0.50 23.62%
2019 $-0.40 -55.51%
2018 $-0.91 -8.85%
2017 $-1.00 7.56%
2016 $-0.93 5.28%
2015 $-0.88 11.82%
2014 $-0.79 68.20%
2013 $-0.47 68.81%
2012 $-0.28 -161.13%
2011 $0.45 -136.44%
2010 $-1.24 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$8.37 -3,496.92%
US
$5.91 -2,499.88%
FR
$0.56 -326.26%
DE
$4.93 -2,102.39%
JP
$3.95 -1,703.08%
US